Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature. (2020)
Attributed to:
Development of intracellular VNARs as novel tools to dissect intracellular biological processes
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d0nr02962a
PubMed Identifier: 32626858
Publication URI: http://europepmc.org/abstract/MED/32626858
Type: Journal Article/Review
Volume: 12
Parent Publication: Nanoscale
Issue: 27
ISSN: 2040-3364